iPSC models of hereditary cancer predisposition: Mechanistic insights into premalignant evolution and lineage-specific vulnerability.

Authors

Bei-Bei Gan, Qing-Bo Yang, Wen-Liang Li, Ning Xu

Published in

Biochimica et biophysica acta. Reviews on cancer. Pages 189695. Aug 26, 2026. Epub Aug 26, 2026.

Abstract

Hereditary cancer carrier tissues are difficult to sample before transformation, limiting direct study of early disease evolution. Induced pluripotent stem cells (iPSCs) preserve inherited genetic context and enable controlled reconstruction of susceptible lineages and defined second hits. Across hereditary breast and ovarian cancer, mismatch repair deficiency, Li-Fraumeni syndrome and familial adenomatous polyposis, current evidence is strongest but uneven for BRCA1/2/PALB2-, MMR-, TP53- and APC-associated models. Collectively, these systems show that lineage state, contextual stress and acquired second hits shape DNA-repair defects, clonal selection and premalignant evolution. However, developmental immaturity, incomplete stromal and immune context, clonal drift and protocol variability constrain interpretation. iPSC models should therefore be used as mechanistic filters for testing causality, comparing lineage vulnerability and prioritising biomarkers or prevention hypotheses, rather than as stand-alone predictors of individual cancer risk or clinical outcome. Their outputs require validation in adult tissues, patient-derived models and carrier cohorts.

PMID:
42648386
Bibliographic data and abstract were imported from PubMed on 27 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.